Neuropathology and Amyloid-β Spectrum in a Bapineuzumab Immunotherapy Recipient

The field of Alzheimer’s disease (AD) research eagerly awaits the results of a large number of Phase III clinical trials that are underway to investigate the effectiveness of anti-amyloid-β (Aβ) immunotherapy for AD. In this case report, we review the pertinent clinical history, examine the neuropat...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Roher, Alex E., Maarouf, Chera L., Daugs, Ian D., Kokjohn, Tyler A., Hunter, Jesse M., Sabbagh, Marwan N., Beach, Thomas G.
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3172868/
https://ncbi.nlm.nih.gov/pubmed/21263194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-2011-101809
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires